Protection from rebleeding before early aneurysm surgery

Seminars in Neurosurgery

Volumn 11, Issue 1, 2000, Pages 3-16

  Leipzig, T J ^a   Horner, T G ^a   Payner, T D ^a   Redelmen, K ^a  

^a Indianapolis Neurosurgical Group   (United States)

Author keywords

Aneurysm; Antifibrinolytic therapy; Rebleed

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT;

ADULT; AGED; ANEURYSM SURGERY; ARTICLE; BRAIN ARTERY ANEURYSM RUPTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EXCRETION; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; FIBRINOLYSIS; HUMAN; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MYOPATHY; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; RISK; SACCULAR ANEURYSM; SUBARACHNOID HEMORRHAGE; THROMBOCYTE DYSFUNCTION;

EID: 0033803238     PISSN: 15268012     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-11553     Document Type: Article

References (58)

1. The risk of rebleeding from ruptured intracranial aneurysms
2. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results
3. Management of cerebral aneurysms: Further facts and additional myths
4. Timing of operation for ruptured aneurysms: Early surgery
5. The natural history of aneurysms and arteriovenous malformations
6. Review of the management of saccular aneurysms
7. Timing of aneurysm surgery
8. Principles of management of subarachnoid hemorrhage: General management
9. Principles of management of subarachnoid hemorrhage: Induced hypotension
10. Significance of 'ultra-early' rebleeding in subarachnoid hemorrhage
11. Reducing the risk of rebleeding before early aneurysm surgery: A possible role for antifibrinolytic therapy
12. Antifibrinolytic therapy for intracranial aneurysms
13. The complications of therapy with epsilon-aminocaproic acid
14. Antifibrinolytic therapy in patients with aneurysreal subarachnoid hemorrhage
15. Antifibrinolytic therapy in patients with aneurysreal subarachnoid hemorrhage
16. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms
17. Aneurysmal rebleeding: A preliminary report from the Cooperative Aneurysm Study
18. Antifibrinolytic therapy in subarachnoid hemorrhage caused by ruptured intracranial aneurysm
19. Impact of medical treatment on the outcome of patients after aneurysmal subarachnoid hemorrhage
20. Antifibrinolytics in aneurysmal subarachnoid hemorrhage: Do they have a role? Maybe
21. Antifibrinolysis with tranexamic acid in aneurysmal subarachnoid hemorrhage: A consecutive controlled clinical trial
22. Antifibrinolytic therapy in the acute period following aneurysmal subarachnoid hemorrhage. Preliminary observations from the Cooperative Aneurysm Study
23. Antifibrinolytics in subarachnoid hemorrhage. Do they have a role? No
24. Antifibrinolytic treatment in subarachnoid hemorrhage
25. Antifibrinolytics in subarachnoid hemorrhage
26. The initial medical management of ruptured intracranial aneurysms
27. Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage
28. Epsilonaminocaproic acid and recurrent subarachnoid hemorrhage
29. Do antifibrinolytic agents prevent rebleeding after rupture of a cerebral aneurysm? A review
30. Perioperative management of subarachnoid hemorrhage
31. The natural history of intracranial aneurysms: Rebleeding rates during the acute and long term period and implication for surgical management
32. Deterruination of tranexamic acid (ACMA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid hemorrhage
33. The absorption, distribution and excretion of epsilon-aminocaproic acid following oral or intravenous administration to man
34. Monitoring antifibrinolytic therapy in subarachnoid hemorrhage
35. Ultra-early rebleeding in spontaneous subarachnoid hemorrhage
36. Surgical risk as related to time of intervention in the repair of intracranial aneurysms
37. Hemodilution for cerebral ischemia
38. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results
39. Principles of management of subarachnoid hemorrhage: Pathophysiplogy and management of hydrocephalus after subarachnoid hemorrhage
40. Management of subarachnoid hemorrhage
41. Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: Epsilon-amino-caproic acid as a possible predisposing factor
42. Aspirin and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage
43. Myopathy induced by epsilon-aminocaproic acid
44. High dose epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage
45. Fibrinolysis and subarachnoid hemorrhage. Inhibitory effect of tranexamic acid. A clinical study
46. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage. A systematic review
47. Retrograde suction decompression of an ophthalmic artery aneurysm using balloon occlusion. Technical note
48. Deep hypothermic circulatory arrest for the management of complex anterior and posterior circulation aneurysms
49. Ultra-early rebleeding within six hours after aneurysm rupture
50. Rebleeding of ruptured intracranial aneurysms in the acute stage
51. Rebleeding from intracranial aneurysms
52. Aneurysmal rupture during angiography
53. Principles of management of subarachnoid hemorrhage: Antifibrinolysis
54. Prevention of postoperative intracerebral hemorrhage with topical recombinant factor XIII in the rat
55. Earlier operation and antifibrinolytic therapy in management of aneurysmal subarachnoid hemorrhage. Review of recent experience in Tasmania
56. Management of 136 consecutive supratentorial berry aneurysms